Skip to content

Cancer Research Grows Hope

Your support makes a difference!

Research is the key

For over 80 years, the Cancer Research Society (CRS) has invested more than $450 million in research grants and fellowships, demonstrating its crucial role in advancing cancer research across Canada.

Thanks to the generosity of thousands of donors and various partners, significant progress continues to be made in cancer prevention, early detection, and treatment, highlighting the CRS’ impact on patients affected by the disease and their families.

Our impact

REVEAL THE IMPACT OF YOUR GIFT

Find the type of donation that suits you best with our Giftabulator.

Whether it’s a cash gift, a gift of securities, a legacy gift, or a life insurance donation, in just a few clicks, visualize how to maximize your tax benefits, while supporting cancer research.

Access the Giftabulator

supporting advances

Through our funding programs, we support hundreds of researchers at different stages of their careers, whether they are established researchers or promising students, all dedicated to making significant advances in the prevention, detection, and treatment of all types of cancer.

Each year, the top-ranked research projects, as determined by our expert committees, receive the necessary funding.

Discover our funding programs

Your support is essential

Your donations and commitment are essential to continue our mission and minimize the impact of cancer in our lives. Discover how you can make a difference for the cause.

News

Apr 15, 2026
  • Research
Renewed Support for Lung Cancer Research 
April 15, 2026 –The Cancer Research Society (CRS) announces the launch of the second edition of its Lung Cancer Research Grants Competition, backed by a total investment of $2 million. Building on the success of its inaugural competition, this initiative aims to accelerate scientific progress in an area where significant needs remain.
Mar 27, 2026
  • Research
Two New Experts Join the Scientific Advisory Committee 
March 27, 2026 – The Cancer Research Society (CRS) is proud to announce the appointment of two new members to its Scientific Advisory Committee.
Mar 25, 2026
  • Research
Supporting Prostate Cancer Research 
March 25, 2026 – The Cancer Research Society (CRS), in partnership with PROCURE, announces a major investment of $3 million to support six innovative research projects on prostate cancer.
Feb 2, 2026
  • Research
A clinical trial to treat young children 
February 2, 2026 – The Cancer Research Society (CRS) is proud to announce the launch of the pan-Canadian clinical trial DECRYPT-BABYBRAIN, aimed at treating rare and aggressive brain cancers in babies and young children.
Jan 27, 2026
  • Research
Joining Forces to Outsmart Rare Brain Cancers
January 27, 2026 – The Cancer Research Society (CRS) is proud to support a groundbreaking initiative dedicated to rare brain tumours in children and young adults.